AMH and female reproductive system neoplasm: Several studies have suggested that MIS/AMH inhibits growth in tissues and cell lines of other MIS/AMH receptor-expressing gynecologic tumors, such as cervical, endometrial, and breast cancers, as well as endometriosis, but its downstream regulatory signaling pathways have not been fully elucidated 14-19.